Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis

Background: Resistant starch type 2 (RS2) has been documented to regulate gut microbiota and to improve the clinical outcomes of several diseases. However, whether RS2 may benefit patients with end-stage renal disease under maintenance hemodialysis (MHD) remains unknown. Methods: We conducted a syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Linpei, Dong, Xingtong, Li, Xiaoxia, Jia, Rufu, Zhang, Hong-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797550/
https://www.ncbi.nlm.nih.gov/pubmed/33437217
http://dx.doi.org/10.7150/ijms.51484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797550/
https://www.ncbi.nlm.nih.gov/pubmed/33437217
http://dx.doi.org/10.7150/ijms.51484

Ejemplares similares